Primary |
Peripheral T-cell Lymphoma Unspecified |
14.3% |
Premedication |
14.1% |
Hypertension |
12.2% |
T-cell Lymphoma |
10.5% |
Mycosis Fungoides |
8.6% |
Nausea |
5.1% |
Pain |
4.3% |
Constipation |
3.5% |
Lymphoma |
3.5% |
Peripheral T-cell Lymphoma Unspecified Recurrent |
3.0% |
Vomiting |
3.0% |
Gastrointestinal Pain |
2.4% |
Mycosis Fungoides Stage Iii |
2.2% |
Anticoagulant Therapy |
1.9% |
Eczema |
1.9% |
Fatigue |
1.9% |
Hypokalaemia |
1.9% |
Infection |
1.9% |
Osteoarthritis |
1.9% |
Vitamin Supplementation |
1.9% |
|
Vomiting |
11.2% |
Lymphopenia |
8.2% |
Unresponsive To Stimuli |
8.2% |
Pyrexia |
7.1% |
Febrile Neutropenia |
6.1% |
Pain |
6.1% |
Mental Status Changes |
5.1% |
Sepsis |
5.1% |
Thrombocytopenia |
5.1% |
Weight Increased |
5.1% |
Capillary Leak Syndrome |
4.1% |
Infection |
4.1% |
Neoplasm Malignant |
4.1% |
Rhabdomyolysis |
4.1% |
Atrial Tachycardia |
3.1% |
Syncope |
3.1% |
Thrombosis |
3.1% |
Tumour Lysis Syndrome |
3.1% |
Acute Graft Versus Host Disease In Intestine |
2.0% |
Blindness |
2.0% |
|
Secondary |
Peripheral T-cell Lymphoma Unspecified |
33.3% |
Premedication |
20.7% |
Mycosis Fungoides |
6.0% |
Prophylaxis |
6.0% |
Infection |
4.0% |
Pain |
4.0% |
T-cell Lymphoma |
3.3% |
B-cell Lymphoma |
2.7% |
Depression |
2.7% |
Hypercholesterolaemia |
2.7% |
Hypertension |
2.7% |
Hypothyroidism |
2.7% |
Anaplastic Large-cell Lymphoma |
1.3% |
Mycosis Fungoides Stage I |
1.3% |
Mycosis Fungoides Stage Iii |
1.3% |
Ovarian Cancer Metastatic |
1.3% |
Pemphigoid |
1.3% |
Renal Tubular Disorder |
1.3% |
Adult T-cell Lymphoma/leukaemia |
0.7% |
Oedema Peripheral |
0.7% |
|
Thrombocytopenia |
14.3% |
Pruritus |
11.4% |
Pyrexia |
8.6% |
Gastrointestinal Disorder |
5.7% |
Generalised Oedema |
5.7% |
Pain |
5.7% |
Skin Lesion |
5.7% |
Skin Necrosis |
5.7% |
Tumour Lysis Syndrome |
5.7% |
Bone Pain |
2.9% |
Capillary Leak Syndrome |
2.9% |
Death |
2.9% |
Enterocolitis Haemorrhagic |
2.9% |
Lymphopenia |
2.9% |
Oedema Peripheral |
2.9% |
Pain In Extremity |
2.9% |
Pancytopenia |
2.9% |
Peripheral Sensory Neuropathy |
2.9% |
Pneumonitis |
2.9% |
Pulmonary Fibrosis |
2.9% |
|
Concomitant |
Eczema |
77.8% |
Product Used For Unknown Indication |
22.2% |
|
White Blood Cell Count Increased |
57.1% |
Sunburn |
28.6% |
Asthenia |
14.3% |
|